Most Commented
- Cubadebate opens its new Web page in English| 20
- Mandela is dead: Why hide the truth about Apartheid?| 11
- El Paso Diary: The Battle Over the Solo Fax| 10
- President Hugo Chavez's address to the People of Venezuela| 10
- Free the Five is heard at Left Forum| 6
- May every citizen be a constituent| 6
- Raúl receives Kim Yong Chol, Special Envoy of the President of the Workers’ Party of Korea| 6
- The Unsustainable Position of the Empire| 5
- U.S. government promoting Internet aggression against Cuba| 5
- NATO’s Genocidal Role| 4
- The Fiftieth Anniversary Parade| 4
- El Paso Diary: The Tip of the Iceberg| 4
Series
- Cuba's Reasons
- Cuban Five
- El Paso Diary
The El Paso Diary is written by José Pertierra--an attorney who represents the government of Venezuela in its request for the extradition of Luis Posada Carriles. Pertierra´s journals describe the testimony, evidence, legal skirmishes, quirks and follies of this very historic trial that features for the first time the close collaboration of the United States government with Cuban authorities to prosecute an ex CIA agent who is one of the masterminds of the fifty-year old dirty war against Cuba.
Authors
- Bernie Dwyer
- Bruno Rodríguez Parrilla
- Deisy Francis Mexidor
- Fidel Castro Ruz
- José Pertierra
- Raúl Castro Ruz
- Ricardo Alarcón de Quesada
- Amy Goodman
- Arleen Rodríguez Derivet
- Frei Betto
- Hugo Chávez Frías
- Josh R. Nelson
- Juan Gelman
- Luis Rumbaut
- Michael Moore
- Mumia Abu-Jamal
- Noam Chomsky
- Reinaldo Taladrid Herrero
- Richard Gott
- Tom Hayden
Articles of cáncer
News »
Cuba develops biopharmaceuticals to treat cancer
Cuba currently has a total of 28 drugs registered, or in various stages of investigation, for the treatment of cancer, which include therapeutic vaccines, monoclonal antibodies, interferons and peptides, developed in different scientific institutions linked to the country’s biotechnology sector.
News »
Cuban lung cancer medicine receives Innovation Award
Registered in Cuba since 2012 after being approved by the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed), the product shows positive results in prolonging and improving the quality of patients’ lives, and has low toxicity levels resulting in less of the unpleasant side effects associated with other necessary therapeutic procedures.
News »
Malaysian firm to market Cuban vaccine against cancer
Malaysian biotechnology firm Bioven, which is currently undertaking Phase III clinical trials of a promising Cuban vaccine against cancer, plans to list the medicine on the London stock exchange, following a fruitful collaboration with Cuba. The relationship of the Caribbean country with Bioven, a company in which the Malaysian government is one of the major shareholders, is an example of South-South cooperation, Elnartd Blanco, commercial manager of CIMAB, the distributor for the Cuban Center of Molecular Immunology (CIM), who created the vaccine, told Prensa Latina.
News »
Cuba Concludes Int”l Workshop on Anti-Cancer Vaccine
More than 100 Cuban and foreign researchers continues debating today in Havana on progresses and new actions of CIMAvax-EGF, first therapeutic vaccine registered for lung cancer. The event, to be concluded today, was opened yesterday at the Havana’s Conference Center, an excellent opportunity to assess new strategies of the medicine, such as its implementation in medical practice, indications and therapeutic combinations.